Psychiatry and Neurology, Neurology · Boise, ID
NPI
1548452683
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
125 E Idaho St Ste 300, Neurology
Boise, ID, 83712
Phone (208) 381-7335
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
401 services
Medicare patients, 2024
239
Average age 61
Drug cost, 2024
$2.0M
3,921 prescriptions
Company payments, 2025
$1,094
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sergei V Kashirny was code 99214 (office e&m - established), 112 times for 83 patients. In total Sergei V Kashirny billed 401 services in 21 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 112 | 83 | $56.22 | $6,296 |
| 99213 Office E&M - Established | Facility | 60 | 55 | $33.59 | $2,015 |
| 95720 Neurologic | Facility | 59 | 33 | $150.80 | $8,897 |
| 95819 Neurologic | Facility | 34 | 34 | $40.63 | $1,381 |
| 95816 Neurologic | Facility | 23 | 23 | $35.26 | $811 |
| 99215 Office E&M - Established | Facility | 15 | 13 | $106.63 | $1,599 |
| 99204 Office E&M - New | Facility | 14 | 14 | $68.91 | $965 |
| 95723 Neurologic | Facility | 13 | 13 | $183.29 | $2,383 |
| 95718 Neurologic | Facility | 11 | 11 | $98.09 | $1,079 |
By year: 2022 $33K for 456 services; 2023 $31K for 408 services; 2024 $29K for 401 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sergei V Kashirny prescribed most often to Medicare patients was Levetiracetam, with 472 prescriptions and refills. In total Sergei V Kashirny wrote 3,921 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 472 | 931 | 112 | $20K |
| Lacosamide Generic | 357 | 454 | 57 | $49K |
| Xcopri Cenobamate | 329 | 342 | 34 | $431K |
| Lamotrigine Generic | 221 | 380 | 40 | $5,727 |
| Divalproex Sodium Er Divalproex Sodium | 212 | 281 | 33 | $12K |
| Clobazam Generic | 164 | 180 | 23 | $23K |
| Levetiracetam Er Levetiracetam | 140 | 265 | 39 | $9,586 |
| Clonazepam Generic | 132 | 155 | 22 | $1,058 |
| Lamotrigine Er Lamotrigine | 130 | 167 | 18 | $43K |
| Zonisamide Generic | 126 | 218 | 24 | $13K |
| Gabapentin Generic | 115 | 175 | 30 | $2,644 |
| Oxcarbazepine Generic | 87 | 131 | 13 | $5,780 |
| Epidiolex Cannabidiol (Cbd) | 75 | 75 | Under 11 | $246K |
| Aptiom Eslicarbazepine Acetate | 74 | 74 | Under 11 | $168K |
| Topiramate Generic | 73 | 154 | 15 | $1,536 |
Brand drugs: 989 claims; generic drugs: 2,913 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sergei V Kashirny $1,094 ($1,094 in general payments such as food, travel and fees) from 11 companies. The largest payer was Jazz Pharmaceuticals Inc. with $303.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $303 |
| UCB, Inc. UCB.BR | 9 | $234 |
| Neuropace, Inc. NPCE | 1 | $233 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $110 |
| LivaNova USA, Inc. LIVN | 2 | $72.16 |
| SK Life Science, Inc. | 1 | $35.34 |
| Neurelis, Inc. | 1 | $28.41 |
| Genentech USA, Inc. ROG.SW | 1 | $24.74 |
| TG Therapeutics, Inc. TGTX | 1 | $22.82 |
| Catalyst Pharmaceuticals, Inc. CPRX | 1 | $15.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.